Cinctive Capital Management LP purchased a new stake in shares of The Allstate Co. (NYSE:ALL – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 16,450 shares of the insurance provider’s stock, valued at approximately $3,120,000.
Other institutional investors have also added to or reduced their stakes in the company. BDF Gestion bought a new position in shares of Allstate during the 2nd quarter valued at approximately $3,051,000. OFI Invest Asset Management bought a new stake in shares of Allstate in the 2nd quarter worth about $476,000. Diversified Trust Co raised its position in shares of Allstate by 505.3% during the 2nd quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after buying an additional 6,614 shares in the last quarter. Eagle Asset Management Inc. lifted its holdings in shares of Allstate by 38.0% in the 3rd quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock valued at $2,067,000 after acquiring an additional 2,888 shares during the last quarter. Finally, Cetera Investment Advisers grew its position in Allstate by 351.6% in the first quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock worth $11,284,000 after acquiring an additional 50,780 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insider Transactions at Allstate
In other news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.80% of the company’s stock.
Allstate Stock Down 1.4 %
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business’s revenue was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.81 EPS. Sell-side analysts expect that The Allstate Co. will post 16.26 earnings per share for the current year.
Allstate Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a dividend yield of 1.80%. Allstate’s dividend payout ratio is currently 23.83%.
Analysts Set New Price Targets
ALL has been the topic of a number of recent research reports. JPMorgan Chase & Co. upped their price objective on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods increased their price target on Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a report on Wednesday, November 6th. The Goldman Sachs Group lifted their price objective on shares of Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. Jefferies Financial Group increased their target price on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, TD Cowen lifted their price target on shares of Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and an average target price of $217.19.
Read Our Latest Analysis on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- What Are the U.K. Market Holidays? How to Invest and Trade
- How to Master Trading Discipline: Overcome Emotional Challenges
- What is the S&P 500 and How It is Distinct from Other Indexes
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- How to Choose Top Rated Stocks
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.